Published in J Natl Cancer Inst on October 01, 1997
Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study. J Clin Oncol (2013) 2.73
Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst (2010) 1.76
Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci U S A (2005) 1.52
Regular review: Managing testicular cancer. BMJ (2001) 1.43
Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype. Endocr Relat Cancer (2010) 1.41
Increased pancreatic cancer risk following radiotherapy for testicular cancer. Br J Cancer (2016) 1.38
Risk factors for cutaneous malignant melanoma among aircrews and a random sample of the population. Occup Environ Med (2003) 1.20
A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation. Radiat Environ Biophys (2009) 1.14
A new view of radiation-induced cancer: integrating short- and long-term processes. Part I: approach. Radiat Environ Biophys (2009) 1.11
Gastrointestinal radiation injury: symptoms, risk factors and mechanisms. World J Gastroenterol (2013) 1.06
Pure seminoma: a review and update. Radiat Oncol (2011) 1.06
Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG). Br J Cancer (2004) 1.04
Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. J Natl Cancer Inst (2012) 1.04
Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance. Cancer Med (2014) 1.01
Update on management of seminoma. Indian J Urol (2010) 0.99
Molecular dynamic simulations of cisplatin- and oxaliplatin-d(GG) intrastand cross-links reveal differences in their conformational dynamics. J Mol Biol (2007) 0.99
Bladder cancer in cancer patients: population-based estimates from a large Swedish study. Br J Cancer (2009) 0.98
Uncertainty during the transition from cancer patient to survivor. Cancer Nurs (2009) 0.96
Quality of life of testicular cancer survivors and the relationship with sociodemographics, cancer-related variables, and life events. Support Care Cancer (2005) 0.96
Screening for new primary cancers in cancer survivors compared to non-cancer controls: a systematic review and meta-analysis. J Cancer Surviv (2013) 0.93
Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma. J Clin Oncol (2008) 0.93
Multiple primary malignancies in patients with prostate cancer: increased risk of secondary malignancies after radiotherapy. Int J Clin Oncol (2012) 0.93
Increased mortality rates in young and middle-aged patients with malignant germ cell tumours. Br J Cancer (2004) 0.92
Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link. Biochemistry (2007) 0.91
Risk of leukemia among survivors of testicular cancer: a population-based study of 42,722 patients. Ann Epidemiol (2008) 0.89
Health behaviors and depressive symptoms in testicular cancer survivors. Urology (2007) 0.87
Second cancers in patients with neuroendocrine tumors. PLoS One (2013) 0.86
Treating prostate cancer with radiotherapy. Nat Rev Clin Oncol (2010) 0.86
Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma. Br J Cancer (2013) 0.85
Clinical characteristics of cutaneous melanoma and second primary malignancies in a dutch hospital-based cohort of cutaneous melanoma patients. Dermatol Res Pract (2009) 0.85
Increased stomach cancer risk following radiotherapy for testicular cancer. Br J Cancer (2014) 0.84
CT of the chest can hinder the management of seminoma of the testis; it detects irrelevant abnormalities. Br J Cancer (2007) 0.84
Testis cancer survivors' health behaviors: comparison with age-matched relative and demographically matched population controls. J Clin Oncol (2010) 0.84
Testis cancer. Postgrad Med J (2007) 0.84
Biology of childhood germ cell tumours, focussing on the significance of microRNAs. Andrology (2014) 0.83
Risk of second primary cancers after testicular cancer in East and West Germany: a focus on contralateral testicular cancers. Asian J Androl (2014) 0.83
TRA-1-60(+), SSEA-4(+), POU5F1(+), SOX2(+), NANOG(+) Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Testes. J Stem Cell Res Ther (2013) 0.83
A new view of radiation-induced cancer. Radiat Prot Dosimetry (2010) 0.83
Quality of life of survivors of testicular germ cell cancer: a review of the literature. Support Care Cancer (2004) 0.83
Persistence of cisplatin-induced mutagenicity in hematopoietic stem cells: implications for secondary cancer risk following chemotherapy. Toxicol Sci (2014) 0.83
Late recurrence and second primary malignancy among 139 patients with germ cell tumors: long-term outcome of the disease in a single-center experience. Jpn J Clin Oncol (2009) 0.82
Introduction: connexins, pannexins and their channels as gatekeepers of organ physiology. Cell Mol Life Sci (2015) 0.81
Clinical stage I seminoma: the case for surveillance. World J Urol (2009) 0.81
Breast and cervical cancer screening behaviours among colorectal cancer survivors in Nova Scotia. Curr Oncol (2014) 0.80
DNA topoisomerases participate in fragility of the oncogene RET. PLoS One (2013) 0.79
What is the value of routine follow-up in stage I seminoma after paraaortic radiotherapy?: an analysis of the German Testicular Cancer Study Group (GTCSG) in 675 prospectively followed patients. Strahlenther Onkol (2009) 0.78
Etiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosis. Asian J Androl (2015) 0.78
The role of fragile sites in sporadic papillary thyroid carcinoma. J Thyroid Res (2012) 0.77
Prediction of metastatic status in non-seminomatous testicular cancer. World J Urol (2013) 0.77
Cost analysis of adjuvant management strategies in early stage (stage I) testicular seminoma. Res Rep Urol (2015) 0.76
Cutaneous Ewing's sarcoma secondary to chemotherapy given for testis tumor: Case report. Int J Surg Case Rep (2014) 0.76
Adenocarcinoma of the seminal vesicles complicated by antineutrophil cytoplasmic antibody vasculitis: a case report and review of the literature. J Med Case Rep (2013) 0.75
A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects. Cancer Med (2013) 0.75
Adjuvant radiotherapy outcome of stage I testicular seminoma: a single institution study. Yonsei Med J (2015) 0.75
Zebrafish Germ Cell Tumors. Adv Exp Med Biol (2016) 0.75
A 55-Year-Old Man with Stage IV Squamous Cell Carcinoma of the Right Groin after External Beam Radiation for Testicular Cancer. Case Rep Urol (2014) 0.75
Metachronous occurrence of triple malignancies of kidneys, prostate, and breast. A case report and review of the literature. Case Rep Urol (2013) 0.75
Stage I seminoma: treatment outcome at King Hussein Cancer Center in Jordan. BMC Urol (2012) 0.75
The story of second cancers in patients cured of testicular cancer: tarnishing success or burnishing irrelevance? J Natl Cancer Inst (1997) 0.75
Treatment options for clinical stage 1 testis cancer. Proc (Bayl Univ Med Cent) (2000) 0.75
Recent developments in the management of germ cell tumors. Curr Opin Oncol (2017) 0.75
Prediagnosis Body Mass Index and Risk of Secondary Primary Cancer in Male Cancer Survivors: A Large Cohort Study. J Clin Oncol (2016) 0.75
Reimbursements and frequency of tests in privately insured testicular cancer patients in the United States: Implications to national guidelines. Urol Ann (2017) 0.75
Successful treatment of disseminated extragonadal germ cell cancer with intensive conventional chemotherapy after first-line high-dose chemotherapy. Int J Clin Oncol (2006) 0.75
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med (2000) 25.49
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68
The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry (1974) 16.18
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med (1997) 10.83
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet (1999) 8.44
Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol (1997) 7.62
Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30
Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer (1999) 6.73
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med (1969) 6.54
A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39
The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med (1993) 6.37
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet (2001) 6.23
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res (1995) 5.72
The Agricultural Health Study. Environ Health Perspect (1996) 5.72
An interspersed repeated sequence specific for human subtelomeric regions. EMBO J (1990) 5.30
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (1999) 5.09
Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol (1994) 4.89
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Does screening by "Pap" smears help prevent cervical cancer? A case-control study. Lancet (1979) 4.81
Why are African Americans under-represented in medical research studies? Impediments to participation. Ethn Health (1997) 4.63
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
Snuff dipping and oral cancer among women in the southern United States. N Engl J Med (1981) 4.33
Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med (1987) 4.12
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
Risk factors for anastomotic leakage after anterior resection of the rectum. Colorectal Dis (2004) 4.02
Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies. J Natl Cancer Inst (1997) 3.89
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol (2003) 3.88
Knowledge of the Tuskegee study and its impact on the willingness to participate in medical research studies. J Natl Med Assoc (2000) 3.82
Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation (1995) 3.82
Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med (2000) 3.72
Drinking water source and chlorination byproducts. I. Risk of bladder cancer. Epidemiology (1998) 3.71
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA (1986) 3.63
Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med (1988) 3.62
Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell (1985) 3.59
Plasma immunoglobulin concentrations in a West African (Gambian) community and in a group of healthy British adults. Clin Exp Immunol (1968) 3.53
Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst (1993) 3.52
Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review. J Natl Cancer Inst (2004) 3.51
Seclusion in prison strip cells. BMJ (1993) 3.44
An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol (1988) 3.39
Risk of cancer in renal-transplant recipients. Lancet (1973) 3.36
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34
Dynamics and species richness of tropical rain forests. Proc Natl Acad Sci U S A (1994) 3.32
Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A (2001) 3.31
Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30
Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26
Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol (1998) 3.24
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
[Low risk of cancer after treatment of hyperthyroidism with iodine-131]. Lakartidningen (1992) 3.22
Coeliac disease--associated disorders and survival. Gut (1994) 3.13
A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13
Aggressiveness of screen-detected breast cancers. Lancet (1995) 3.07
Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet (1977) 3.05
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00
Clues to cancer etiology from studies of farmers. Scand J Work Environ Health (1992) 2.98
Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol (1994) 2.94
Residential 222Rn exposure and lung cancer: testing the linear no-threshold theory with ecologic data. Health Phys (1998) 2.88
Factors that influence African-Americans' willingness to participate in medical research studies. Cancer (2001) 2.86
Risk of breast cancer following low-dose radiation exposure. Radiology (1979) 2.86
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76
Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer (2000) 2.75
Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet (1998) 2.74
Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA (1993) 2.71
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68
Survival of cancer patients in Finland 1955-1994. Acta Oncol (1999) 2.67
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol (1998) 2.65
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11). Clin Cancer Res (2001) 2.64
Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc Natl Acad Sci U S A (1989) 2.59
Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst (2001) 2.59
A population-based case-control study of childhood leukemia in Shanghai. Cancer (1988) 2.59
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
Body-surface area-based dosing does not increase accuracy of predicting cisplatin exposure. J Clin Oncol (2001) 2.52
Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst (1969) 2.50
International trends and patterns of primary liver cancer. Int J Cancer (2001) 2.50
Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol (1991) 2.49
Residential radon exposure and lung cancer among nonsmoking women. J Natl Cancer Inst (1994) 2.45
Antigens associated with Plasmodium falciparum infections in man. Lancet (1969) 2.45
Geographic patterns of lung cancer: industrial correlations. Am J Epidemiol (1976) 2.45
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (1998) 2.43
Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet Gynecol (1992) 2.43
Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ (1997) 2.41
Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States. BMJ (2012) 2.38
Social class as a prognostic factor in breast cancer survival. Cancer (1990) 2.37
Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev (2002) 2.36
Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst (1995) 2.35
Breast cancer and cigarette smoking: a hypothesis. Am J Epidemiol (1991) 2.35